Hubei Biocause Pharmaceutical: Hubei Biocause Pharmaceutical's announcement for the decision of the supervisory board on September 16th.

SZSI · Jun 15

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.